Literature DB >> 35182504

MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19.

Anna Francis1, Jacqueline Palace1, Lars Fugger2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35182504     DOI： 10.1016/S1474-4422(22)00043-6

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  5 in total

Review 1.  MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.

Authors:  S Jarius; N Bieber; J Haas; B Wildemann
Journal:  J Neurol       Date:  2022-06-23       Impact factor: 6.682

2.  Author's response to the commentary: Neuromyelitis optica complicating COVID vaccinations and additional case reports.

Authors:  Nanthaya Tisavipat; Chumpol Anamnart; Weerapat Owattanapanich; Metha Apiwattanakul; Pakawee Savangned; Naraporn Prayoonwiwat; Sasitorn Siritho; Natthapon Rattanathamsakul; Jiraporn Jitprapaikulsan
Journal:  Mult Scler Relat Disord       Date:  2022-07-12       Impact factor: 4.808

3.  Anti-MOG associated disease with intracranial hypertension after COVID-19 vaccination.

Authors:  Lina Jeantin; Adèle Hesters; Dorine Fournier; Bénédicte Lebrun-Vignes; Aurélie Méneret; Caroline Papeix; Valérie Touitou; Elisabeth Maillart
Journal:  J Neurol       Date:  2022-04-23       Impact factor: 6.682

4.  Improved detection of MOG antibody-associated transverse myelitis with 18F-FDG-PET: a case report.

Authors:  F Daems; J Derdelinckx; S Ceyssens; S Vanden Bossche; T Reynders; B Willekens
Journal:  Acta Neurol Belg       Date:  2022-09-22       Impact factor: 2.471

5.  Guilty by association? SARS-CoV-2 antibodies and myelin oligodendrocyte glycoprotein antibody-associated disease.

Authors:  Radu Tanasescu; Markus Reindl
Journal:  Eur J Neurol       Date:  2022-04-03       Impact factor: 6.288
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.